Nuwellis Inc vs UiPath Inc — how do they compare? Nuwellis Inc trades at $2.84 (market cap $1.09M), while UiPath Inc trades at $12.03 (market cap $6.30B). The key difference: UiPath Inc is far larger — about 5779.8× Nuwellis Inc's market cap, and UiPath Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | PATH | |
|---|---|---|
Market Cap | $1.09M | $6.30B |
Sector | Technology | Technology |
52-Week High | $527.46 | $19.29 |
52-Week Low | $2.80 | $9.38 |
Enterprise Value | -$722.58K | $5.08B |
Trailing returns across standard periods
Latest headlines on both assets
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.
Read more on PATH →